News

Prof. Shinsuke Sando at THE UNIVERSITY OF TOKYO and TAGCyx ANNOUNCES THE RESEARCH COLLABORATION of THE TECHNOLOGICAL IMPROVEMENT OF XENOLIGO®

March 22nd, 2021

Prof. Shinsuke Sando at the university of Tokyo

TAGCyx biotechnologies Inc.

 

Prof. Shinsuke Sando at the university of Tokyo, Tokyo, and TAGCyx biotechnologies Inc., Tokyo, announced entering into a research collaboration of the technological improvement of Xenoligo®.

Prof. Shinsuke Sando is an expert in functional molecules: an artificial cell growth factor, an artificial peptide, which is applicable to understanding the phenomena of life.

TAGCyx has invented artificial nucleic acid base-pair technology that enables to produce high avidity and selective functional DNA aptamers “Xenoligo®”.

Both parties intend to collaborative research regarding technological improvement of developing Xenoligo® to be excellent medicine.

 

For further information, please contact:

Prof. Shinsuke Sando

E-Mail: ssando@chembio.t.u-tokyo.ac.jp

 

TAGCyx biotechnologies Inc.

E-Mail: info@tagcyx.com

Comments are closed.